Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia

British Journal of Haematology

Volumn 93, Issue 1, 1996, Pages 59-67

  Anderson, Jeanne E ^a   Anasetti, Claudio ^a   Appelbaum, Frederick R ^a   Schoch, Gary ^a   Gooley, Ted A ^a   Hansen, John A ^a   Buckner, C Dean ^a   Sanders, Jean E ^a   Sullivan, Keith M ^a   Storb, Rainer ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

acute myeloid leukaemia; bone marrow transplantation; myelodysplastic syndrome; secondary leukaemia; unrelated donors

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 9244241477     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.4811022.x     Document Type: Article

References (33)

1. Alessandrino, E.P., Bernasconi, P., Bonfichi, M., Caldera, D., Campagnoli, C., Boni, M. & Bernasconi, C. (1993) Bone marrow transplantation from unrelated donor in myelodysplastic syndromes. Bone Marrow Transplantation, 11, (Suppl. 1), 71-73.
2. Anasetti, C., Hansen, J.A., Waldmann, R.A., Appelbaum, F.R., Davis, J., Deeg, H.J., Doney, K., Martin, P.J., Nash, R., Storb, R., Sullivan, K.M., Witherspoon, R.P., Binger, M.H., Chizzonite, R., Hakimi, J., Mould, D., Satoh, H. & Light, S.E. (1994) Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. Blood, 84, 1320-1327.
3. Anderson, J.E., Anasetti, C., Appelbaum, F.R., Hansen, J.A. & Storb, R. (1994) Allogeneic marrow transplantation for myelodysplastic syndrome (MDS) using unrelated donors (URD). Leukemia Research, 18, (Suppl.), Abstract 26.
4. Anderson, J.E., Appelbaum, F.R., Fisher, L.D., Schoch, G., Shulman, H., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Doney, K., Martin, P.J., Sanders, J.E., Sullivan, K.M., Thomas, E.D., Witherspoon, R.P., Hansen, J.A. & Storb, R. (1993) Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood, 82, 677-681.
5. Anderson, J.E., Appelbaum, F.R., Schoch, G., Gooley, T., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Chauncey, T.R., Clift, R.A., Deeg, J., Doney, K., Flowers, M., Hansen, J.A., Martin, P.J., Matthews, D.C., Nash, R.A., Sanders, J.E., Shulman, H., Sullivan, K.M., Witherspoon, R.P. & Storb, R. (1996a) Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total body irradiation and analysis of prognostic factors. Journal of Clinical Oncology, 14, 220-226.
6. Anderson, J.E., Appelbaum, F.R. & Schoch, G., Gooley, T., Anasetti, C., Bensinger, W.I., Bryant, E., Buckner, C.D., Chauncey, T.R., Clift, R.A., Doney, K., Flowers, M., Hansen, J.A., Martin, P.J., Matthews, D.C., Sanders, J.E., Shulman, H., Sullivan, K.M., Witherspoon, R.P. & Storb, R. (1996b) Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors. Blood, 87, 51-58.
7. Anderson, J.E., Appelbaum, F.R. & Storb, R. (1995) An update on allogeneic marrow transplantation for myelodysplastic syndrome. Leukemia and Lymphoma, 17, 95-99.
8. Aul, C., Gattermann, N., Heyll, A., Germing, U., Derigs, G. & Schneider, W. (1992) Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia, 6, 52-59.
9. Balduzzi, A., Gooley, T., Anasetti, C., Sanders, J.E., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Buckner, C.D., Matthews, D., Storb, R., Sullivan, K.M. & Hansen, J.A. (1995) Unrelated donor marrow transplantation in children. Blood, 86, 3247-3256.
10. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
11. Casper, J., Camitta, B., Truitt, R., Baxter-Lowe, L.A., Bunin, N., Lawton, C., Murray, K., Hunter, J., Pietryga, D., Garbrecht, F., Taylor, C.K., Drobyski, W., Horowitz, M., Flomenberg, N. & Ash, R. (1995) Unrelated bone marrow transplants for children with leukemia or myelodysplasia. Blood, 85, 2354-2363.
12. DeWitte, T., Zwaan, F., Hermans, J., Vernant, J., Kolb, H., Vossen, J., Lonnqvist, B., Beelen, D., Ferrant, A., Gmur, J., Liu Yin, J., Troussard, X., Cahn, J., Van Lint, M. & Gratwohl, A. (1990) Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). British Journal of Haematology, 74, 151-155.
13. Fenaux P., Preudhomme, C. & Hebbar, M. (1992) The role of intensive chemotherapy in myelodysplastic syndromes. Leukemia and Lymphoma. 8, 43-49.
14. Fisher, L.D. & Van Belle, G. (1983) Biostatistics: Methodology for the Health Sciences. John Wiley and Sons, New York.
15. Fung, H., Shepherd, J., Nantel, S., Spinelli, J., Sutherland, H., Klingemann, H., Reece, D., Phillips, G. & Barnett, M. (1995) Allogeneic bone marrow transplantation (BMT) for adults with myelodysplastic syndrome (MDS). Proceedings of the American Society of Clinical Oncology, 14, Abstract 75.
16. Ganser, A. & Hoelzer, D. (1992) Clinical course of myelodysplastic syndromes. Hematology and Oncology Clinics of North America, 6, 607-618.
17. Goasguen, J.E., Garand, R., Bizet, M., Bremond, J.L., Gardais, J., Callat, M.P., Accard, F. & Chaperon, J. (1990) Prognostic factors of myelodysplastic syndromes: a simplified 3-D scoring system. Leukemia Research, 14, 255-262.
18. Jacobs, A. (1991) Genetic lesions in preleukemia. Leukemia, 5, 277-282.
19. Kernan, N.A., Bartsch, G., Ash, R.C., Beatty, P.G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A., Henslee-Downey, J., McCullough, J., McGlave, P., Perkins, H.A., Phillips, G.L., Sanders, J., Stroncek, D., Thomas, E.D. & Blume, K.G. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New England Journal of Medicine 328, 593-602.
20. Longmore, G., Guinan, E.C., Weinstein, H.J., Gelber, R.D., Rappeport, J.M. & Antin, J.H. (1990) Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia. Journal of Clinical Oncology, 8, 1707-1714.
21. Morel, P., Hebbar, M., Lai, J.L., Duhamel, A., Preudhomme, C., Wattel, E., Bauters, F. & Fenaux, P. (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia, 7, 1315-1323.
22. Nash, R.A., Etzioni, R., Storb, R., Furlong, T., Gooley, T., Anasetti, C., Appelbaum, F.R., Doney, K., Martin, P., Slattery, J., Sullivan, K., van der Jagt, R., Witherspoon, R., Jusko, W.J., Zager, R.A. & Deeg, H.J. (1995) Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single center study. Blood, 85, 3746-3763.
23. Nevill, T.J., Shepherd, J.D., Reece, D.E., Barnett, M.J., Nantel, S.H., Klingemann, H.G. & Phillips, G.L. (1992) Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT. Bone Marrow Transplantation, 10, 445-450.
24. O'Donnell, M.R., Long, G.D., Parker, P.M., Niland, J., Nademanee, A., Amylon, M., Chao, N., Negrin, R.S., Schmidt, G.M., Slovak, M.L., Smith, E.P., Snyder, D.S., Stein, A.S., Traweek, T., Blume, K.G. & Forman, S.J. (1995) Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia. Journal of Clinical Oncology, 13, 2973-2979.
25. Petersdorf, E.W., Longton, G.M., Anasetti, C., Martin, P.J., Mickelson, E.M., Smith, A.G. & Hansen, J.A. (1995) The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B. DR identical unrelated donor marrow transplantation. Blood, 86, 1606-1613.
26. Raskind, W., Tirumali, N., Jacobson, R., Singer, J. & Fialkow, P.J. (1984) Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood, 63, 1318-1323.
27. Ratanatharathorn, V., Karanes, C., Uberti, J., Lum, L.G., de Planque, M.M., Schultz, K.R., Cronin, S., Dan, M.E., Mohamed, A., Hussein, M. & Sensenbrenner, L.L. (1993) Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes. Blood, 81, 2194-2199.
28. Sanz, G.F., Sanz, M.A., Vallespi, T., Canizo, M.C., Torrabadella, M., Garcia, S., Irriguible, D. & San Miguel, J.F. (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood, 74, 395-408.
29. Storb, R., Deeg, H.J., Whitehead, J., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Farewell, V., Hansen, J., Hill, R., Lum, L., Martin, P., McGuffin, R., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R., Yee, G. & Thomas, E.D. (1986) Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. New England Journal of Medicine, 314, 729-735.
30. Sutton, L., Leblond, V., Le Maignan, C., Jouet, J.P., Keuntz, M., Gluckman, E., Blaise, D., Marit, G., Attal, M., Troussard, X., Bordigoni, P., Cahn, J.Y. & Ribaud, P. (1991) Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients. Bone Marrow Transplantation, 7, (Suppl. 2), 39.
31. Thomas, E.D. & Clift, R.A. (1989) Indications for marrow transplantation in chronic myelogenous leukemia. Blood, 73, 861-864.
32. Thomas, E.D., Storb, R., Reginald, A.C., Fefer, A., Johnson, F.L., Neiman, P.E., Lerner, K.G., Glucksberg, H. & Buckner, C.D. (1975) Bone marrow transplantation. New England Journal of Medicine, 292, 832-843 and 892-902.
33. Worsley, A., Oscier, D.G., Stevens, J., Darlow, S., Figes, A., Mufti, G.J. & Hamblin, T.J. (1988) Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival. British Journal of Haematology, 68, 17-21.